These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1898534)

  • 1. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT; Heidenreich R; Kaplan P; Levine F; Mazur A; Palmieri MJ; Yudkoff M; Segal S
    N Engl J Med; 1991 Jan; 324(3):175-9. PubMed ID: 1898534
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasogastric drip feeding as the only treatment of neonatal maple syrup urine disease.
    Parini R; Sereni LP; Bagozzi DC; Corbetta C; Rabier D; Narcy C; Hubert P; Saudubray JM
    Pediatrics; 1993 Aug; 92(2):280-3. PubMed ID: 8337030
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK
    Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
    Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
    Parsons H; Fung E; Snyder FF
    N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of hemodialysis in maple syrup urine disease.
    Puliyanda DP; Harmon WE; Peterschmitt MJ; Irons M; Somers MJ
    Pediatr Nephrol; 2002 Apr; 17(4):239-42. PubMed ID: 11956873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total parenteral nutrition therapy of toxic maple syrup urine disease.
    Townsend I; Kerr DS
    Am J Clin Nutr; 1982 Aug; 36(2):359-65. PubMed ID: 6808824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemofiltration in acute neonatal metabolic crisis].
    Ring E; Zobel G
    Wien Klin Wochenschr; 1992; 104(21):674-7. PubMed ID: 1475972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of early and long-term management of classical maple syrup urine disease.
    Clow CL; Reade TM; Scriver CR
    Pediatrics; 1981 Dec; 68(6):856-62. PubMed ID: 6798541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exfoliative erythroderma resulting from inadequate intake of branched-chain amino acids in infants with maple syrup urine disease.
    Northrup H; Sigman ES; Hebert AA
    Arch Dermatol; 1993 Mar; 129(3):384-5. PubMed ID: 8447687
    [No Abstract]   [Full Text] [Related]  

  • 14. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of maple syrup urine disease on resin coated chromatosheets.
    Kovács J
    Acta Biochim Biophys Acad Sci Hung; 1979; 14(3):119-21. PubMed ID: 547666
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective study of maple-syrup-urine disease for the first four days of life.
    DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M
    N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815
    [No Abstract]   [Full Text] [Related]  

  • 17. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.
    Simon E; Wendel U; Schadewaldt P
    Turk J Pediatr; 2005; 47(1):8-13. PubMed ID: 15884622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The intermediate form of maple syrup disease].
    Rittinger O; Bachmann C; Irnberger T; Pilz P; Walter GF; Wendel U; Plöchl E
    Klin Padiatr; 1986; 198(1):37-43. PubMed ID: 3959487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case.
    Lin MC; Chen CH; Fu LS; Jan SL; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2002; 43(5):281-4. PubMed ID: 12607485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched-chain organic acidurias.
    Ogier de Baulny H; Saudubray JM
    Semin Neonatol; 2002 Feb; 7(1):65-74. PubMed ID: 12069539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.